Cargando…

Economic benefits of subcutaneous trastuzumab administration: A single institutional study from Karolinska University Hospital in Sweden

INTRODUCTION: Adjuvant trastuzumab is a standard of care in the treatment of Human Epidermal growth factor Receptor 2 (HER2) positive early breast cancer (eBC). Initially trastuzumab could only be administered intravenously (IV), however since 2013, a subcutaneous (SC) formulation with comparable ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hedayati, Elham, Fracheboud, Lionel, Srikant, Vaidyanathan, Greber, David, Wallberg, Susanne, Linder Stragliotto, Christina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361452/ https://www.ncbi.nlm.nih.gov/pubmed/30716137 http://dx.doi.org/10.1371/journal.pone.0211783

Ejemplares similares

Rare and important medical books in the library of the Karolinska Institute
por: Beasley, Gerald
Publicado: (1994)

Validation of the Colombian version of the Karolinska sleepiness scale
por: Laverde-López, María Camila, et al.
Publicado: (2022)

Comparing two versions of the Karolinska Sleepiness Scale (KSS)
por: Miley, Anna Åkerstedt, et al.
Publicado: (2016)

Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice
por: Waller, Cornelius F., et al.
Publicado: (2021)

Robot-assisted radical cystectomy with intracorporeal neobladder diversion: The Karolinska experience
por: Collins, Justin W., et al.
Publicado: (2014)

The socio-economical impact of intravenous (IV) versus subcutaneous (SC) administration of trastuzumab: future prospectives
por: Papadmitriou, K., et al.
Publicado: (2015)

Development and psychometric testing of a barriers to HIV testing scale among individuals with HIV infection in Sweden; The Barriers to HIV testing scale-Karolinska version
por: Wiklander, Maria, et al.
Publicado: (2015)

Cohort Profile: The Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA)
por: Gabrielson, Marike, et al.
Publicado: (2017)

GUT in FOCUS Symposium NOBEL FORUM, Karolinska Institutet, February 2nd 2015
Publicado: (2015)

Combining the Suicide Intent Scale and the Karolinska Interpersonal Violence Scale in suicide risk assessments
por: Stefansson, J., et al.
Publicado: (2015)

Positive bias for European men in peer reviewed applications for faculty position at Karolinska Institutet
por: Holst, Sarah, et al.
Publicado: (2018)

Recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 13–15 November 2016
por: Ahmed, Niaz, et al.
Publicado: (2017)

Lifestyle characteristics in adolescent female football players: data from the Karolinska football Injury Cohort
por: Fältström, Anne, et al.
Publicado: (2022)

Psychometric and structural properties of the Karolinska Exhaustion Disorder Scale: a 1,072-patient study
por: Lindsäter, Elin, et al.
Publicado: (2023)

Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit
por: Triulzi, Tiziana, et al.
Publicado: (2018)

Chemotherapy Treatment of Elderly Patients (≥70 Years) with Non-Small Cell Lung Cancer: A Seven-Year Retrospective Study of Real-Life Clinical Practice at Karolinska University Hospital, Sweden
por: Koyi, Hirsh, et al.
Publicado: (2015)

Estimating the Product Lifecycle Value of Trastuzumab Based on Registry Data in Sweden
por: Justo, Nahila, et al.
Publicado: (2023)

Evaluating the proposal of paediatric virology: An interview with Professor Tina Dalianis, Professor of Tumour Virology at Karolinska Institutet
por: Mammas, Ioannis N., et al.
Publicado: (2018)

The Karolinska NeuroCOVID study protocol: Neurocognitive impairment, biomarkers and advanced imaging in critical care survivors
por: Nelson, David W., et al.
Publicado: (2022)

The Karolinska KI/K COVID‐19 immune atlas: An open resource for immunological research and educational purposes
por: Ljunggren, Hans‐Gustaf, et al.
Publicado: (2022)

Subcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase
por: Shpilberg, O, et al.
Publicado: (2013)

Development of New Formulations of Biologics: Expectations, Immunogenicity, and Safety for Subcutaneous Trastuzumab
por: Pimentel, Franklin Fernandes, et al.
Publicado: (2018)

Construction and evaluation of a self rating scale for stress-induced Exhaustion Disorder, the Karolinska Exhaustion Disorder Scale
por: Besèr, Aniella, et al.
Publicado: (2014)

Effects of singing bowl exposure on Karolinska sleepiness scale and pupillographic sleepiness test: A randomised crossover study
por: Bergmann, Melanie, et al.
Publicado: (2020)

The concurrent validity of the Lund University Checklist for Incipient Exhaustion and the Karolinska Exhaustion Disorder Scale: a replication study
por: Persson, Roger, et al.
Publicado: (2023)

Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting
por: Joona, Therse Björkin, et al.
Publicado: (2020)

Trastuzumab cardiotoxiciy: the age-old balance of risk and benefit
por: Ewer, Michael S, et al.
Publicado: (2016)

Economic Benefits of Switching From Intravenous to Subcutaneous Epoetin Alfa for the Management of Anemia in Hemodialysis Patients
por: Prasad, Bhanu, et al.
Publicado: (2020)

Cultural Adaptation and Validation of the Barriers to HIV Testing Scale-Karolinska Version for Brazilian Men Who Have Sex With Men
por: Sousa, Laelson Rochelle Milanês, et al.
Publicado: (2023)

Safety profile of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: The French HERmione non-interventional prospective study
por: Jacquin, Jean-Philippe, et al.
Publicado: (2019)

The Karolinska experience of autologous stem-cell transplantation for lymphoma: a population-based study of all 433 patients 1994–2016
por: Carlsten, Mattias, et al.
Publicado: (2019)

A Case Series on Critically Ill Pregnant or Newly Delivered Patients with Covid-19, Treated at Karolinska University Hospital, Stockholm
por: Polcer, Rasha El-ahmad, et al.
Publicado: (2021)

Excellent survival after R‐Hyper‐CVAD in hospitalized patients with high‐risk large B‐cell lymphoma: The Karolinska experience
por: Sonnevi, Kristina, et al.
Publicado: (2021)

Simulating Costs of Intravenous Biosimilar Trastuzumab vs. Subcutaneous Reference Trastuzumab in Adjuvant HER2-Positive Breast Cancer: A Belgian Case Study
por: Simoens, Steven, et al.
Publicado: (2021)

Incidence, Demographics, and Outcomes of Penetrating Trauma in Sweden During the Past Decade
por: Günther, Mattias, et al.
Publicado: (2021)

PRECARIOUS PATHWAYS INTO RETIREMENT AND NEW RISKS FOR GENDERED ECONOMIC EXCLUSION IN SWEDEN, 1990-2015
por: Motel-Klingebiel, Andreas, et al.
Publicado: (2019)

Public Awareness of Sepsis Is Low in Sweden
por: Mellhammar, Lisa, et al.
Publicado: (2015)

Sweden's economic inequality gap is widening and worrying
por: The Lancet Regional Health – Europe
Publicado: (2023)

Editorial: Karolinska Institutet 200-Year Anniversary Symposium on Injuries to the Spinal Cord and Peripheral Nervous System—An Update on Recent Advances in Regenerative Neuroscience
por: Sköld, Mattias K., et al.
Publicado: (2017)

Subcutaneous trastuzumab: development of a new formulation for treatment of HER2-positive early breast cancer
por: Hamizi, Salima, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_soi35nmdi7ul2rmmb9vmb6iomi